Iodinated contrast media differentially affect afferent and efferent arteriolar tone and reactivity in mice: A possible explanation for reduced glomerular filtration rate

Radiology

Volumn 265, Issue 3, 2012, Pages 762-771

  Liu, Zhi Z ^a   Viegas, Vinicius U ^a   Perlewitz, Andrea ^a   Lai, En Y ^b   Persson, Pontus B ^a   Patzak, Andreas ^a   Sendeski, Mauricio M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; IODIXANOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE;

AFFERENT ARTERIOLAR TONE; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY TONE; ARTICLE; BIOAVAILABILITY; CHEMOREACTIVITY; CONTROLLED STUDY; EFFERENT ARTERIOLAR TONE; ENZYME INHIBITION; FLUORESCENCE; GLOMERULUS FILTRATION RATE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; ARTERIOLES; CONTRAST MEDIA; CYCLIC N-OXIDES; DICARBETHOXYDIHYDROCOLLIDINE; ETHYLAMINES; FLUORESCEINS; GLOMERULAR FILTRATION RATE; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; SPIN LABELS; STATISTICS, NONPARAMETRIC; SUPEROXIDES; TRIIODOBENZOIC ACIDS; VASOCONSTRICTION;

EID: 84870004752     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12120044     Document Type: Article

References (32)

1. Briguori C, Tavano D, Colombo A. Contrast agent-associated nephrotoxicity. Prog Cardiovasc Dis 2003;45(6):493-503. (Pubitemid 36666455)
2. McCullough PA, Adam A, Becker CR, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 2006;98(6A):27K-36K.
3. European Society of Urogenital Radiology. ESUR guidelines on contrast media. ESUR Web site. http://www.esur.org/Contrastmedia.51.0.html. Published 2008. Accessed 2011.
4. ACR Committee on Drugs and Contrast Media. ACR manual on contrast media, version Reston, Va: American College of Radiology, 2012. http://www.acr.org/~/ media/ACR/Documents/PDF/QualitySafety/Resources/Contrast%20Manual/FullManual. pdf. Accessed 2011.
5. Sendeski MM. Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol 2011;38(5):292-299.
6. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68(1):14-22. (Pubitemid 43181360)
7. Pugh ND. Haemodynamic and rheological effects of contrast media: the role of viscosity and osmolality. Eur Radiol 1996;6(suppl 2):S13-S15. (Pubitemid 126487657)
8. Heyman SN, Rosen S, Khamaisi M, Idée JM, Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol 2010;45(4):188-195.
9. Ribeiro L, de Assunção e Silva F, Kurihara RS, Schor N, Mieko E, Higa S. Evaluation of the nitric oxide production in rat renal artery smooth muscle cells culture exposed to radiocontrast agents. Kidney Int 2004;65(2):589-596.
10. Tumlin J, Stacul F, Adam A, et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006;98(6A):14K-20K.
11. Möckel M, Radovic M, Kühnle Y, et al. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography. Nephrol Dial Transplant 2008;23(5):1588-1594. (Pubitemid 351767743)
12. Seeliger E, Flemming B, Wronski T, et al. Viscosity of contrast media perturbs renal hemodynamics. J Am Soc Nephrol 2007;18(11):2912-2920. (Pubitemid 350058398)
13. Rauch D, Drescher P, Pereira FJ, Knes JM, Will JA, Madsen PO. Comparison of iodinated contrast media-induced renal vasoconstriction in human, rabbit, dog, and pig arteries. Invest Radiol 1997;32(6):315-319. (Pubitemid 27237567)
14. Sendeski M, Patzak A, Pallone TL, Cao C, Persson AE, Persson PB. Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. Radiology 2009;251(3):697-704.
15. Sendeski M, Patzak A, Persson PB. Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents. Invest Radiol 2010;45(8):453-457.
16. Patzak A, Lai EY, Mrowka R, Steege A, Persson PB, Persson AEG. AT1 receptors mediate angiotensin II-induced release of nitric oxide in afferent arterioles. Kidney Int 2004;66(5):1949-1958. (Pubitemid 41094319)
17. Patzak A, Mrowka R, Storch E, Hocher B, Persson PB. Interaction of angiotensin II and nitric oxide in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 2001;12(6):1122-1127. (Pubitemid 32472625)
18. Garvin JL, Hong NJ. Cellular stretch increases superoxide production in the thick ascending limb. Hypertension 2008;51(2):488-493. (Pubitemid 351156437)
19. Brunner E, Langer F. Nichtparametrische analyse longitudinaler daten. Munich, Germany: R Oldenbourg Verlag, 1999.
20. R Development Core Team. R: a language and environment for statistical computing, reference index version 2.8.1. http://www.r-project.org/. Accessed 2011.
21. Gruskin AB, Auerbach VH, Black IF. Intrarenal blood flow in children with normal kidneys and congenital heart disease: changes attributable to angiography. Pediatr Res 1974;8(5):561-572.
22. Morris TW, Katzberg RW, Fischer HW. A comparison of the hemodynamic responses to metrizamide and meglumine/sodium diatrizoate in canine renal angiography. Invest Radiol 1978;13(1):74-78. (Pubitemid 8292618)
23. Wong PC, Li Z, Guo J, Zhang A. Pathophysiology of contrast-induced nephropathy. Int J Cardiol 2012;158(2):186-192.
24. Heyman SN, Clark BA, Kaiser N, et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992;3(1):58-65.
25. Thomsen HS, Morcos SK, Barrett BJ. Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 2008;49(6):646-657.
26. Arendshorst WJ, Brännström K, Ruan X. Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 1999;10(suppl 11):S149-S161. (Pubitemid 29038180)
27. Persson AE, Gutierrez A, Pittner J, et al. Renal NO production and the development of hypertension. Acta Physiol Scand 2000;168(1):169-174. (Pubitemid 30128684)
28. Navar LG, Nishiyama A. Why are angiotensin concentrations so high in the kidney? Curr Opin Nephrol Hypertens 2004;13(1):107-115. (Pubitemid 39069906)
29. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44(7):1393-1399. (Pubitemid 39303939)
30. Chong E, Poh KK, Liang S, Soon CY, Tan HC. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J Interv Cardiol 2010;23(5):451-459.
31. Nyman U, Björk J, Aspelin P, Marenzi G. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radiol 2008;49(6):658-667.
32. Patzak A, Lai E, Persson PB, Persson AE. Angiotensin II-nitric oxide interaction in glomerular arterioles. Clin Exp Pharmacol Physiol 2005;32(5-6):410-414. (Pubitemid 40780267)